Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU – Get Free Report)’s stock price dropped 0.5% on Wednesday . The company traded as low as $10.49 and last traded at $10.49. Approximately 2,000 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 32,424 shares. The stock had previously closed at $10.54.
Drugs Made in America Acquisition Stock Down 0.5%
The stock has a 50 day moving average price of $10.49 and a two-hundred day moving average price of $10.46.
About Drugs Made in America Acquisition
Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
Further Reading
- Five stocks we like better than Drugs Made in America Acquisition
- Energy and Oil Stocks Explained
- Why Gold Loves Trump as Much as Trump Loves Gold
- Stock Market Upgrades: What Are They?
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Receive News & Ratings for Drugs Made in America Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drugs Made in America Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
